Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease

BACKGROUND: Vedolizumab is safe and effective in adult patients with Crohn’s disease (CD) and ulcerative colitis (UC); however, data in children with inflammatory bowel disease (IBD) are scarce. Therefore, we evaluated vedolizumab use in a cohort of Austrian paediatric patients with IBD. METHODS: Tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Anna-Maria, Weghuber, Daniel, Hetzer, Benjamin, Entenmann, Andreas, Müller, Thomas, Zimmermann, Georg, Schütz, Sebastian, Huber, Wolf-Dietrich, Pichler, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139155/
https://www.ncbi.nlm.nih.gov/pubmed/30219028
http://dx.doi.org/10.1186/s12876-018-0868-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139155/
https://www.ncbi.nlm.nih.gov/pubmed/30219028
http://dx.doi.org/10.1186/s12876-018-0868-x

Ejemplares similares